Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 219200
Company: ALKEM LABS LTD
Company: ALKEM LABS LTD
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LUMATEPERONE | LUMATEPERONE | 10.5MG | CAPSULE | None (Tentative Approval) | None | No | No |
| LUMATEPERONE | LUMATEPERONE | 21MG | CAPSULE | None (Tentative Approval) | None | No | No |
| LUMATEPERONE | LUMATEPERONE | 42MG | CAPSULE | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/27/2025 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |